An extract of Crataegus-WS 1442-standardized by a special process of production and adjusted to 18.75% oligomeric procyanidines, was investigated in single and repeat-dose toxicity studies. No target organ toxicity was defined at high multiples of the human dose (100 times) and the battery of standard mutagenic and clastogenic tests were negative. The results presented are for Crataegus extract WS 1442 only; other preparations of Crataegus have to be investigated case by case.
Aeschbacher HU. (1982) The significance of mutagens in food. In: Sorsa M, Vainio H, eds. Mutagens in our Environment. New York: Alan R. Liss, 349–62.
2.
Afanas'ev IB, Dodrozhko AI, Brodskii AV, Kostyuk VA, Potapovitch AI. (1989) Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol38:1763–9.
3.
Brown JP. (1980) A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutat Res75:243–77.
4.
Buening MK, Chang RL, Huang MT, Fortner JG, Wood AW, Conney AH. (1981) Activation and inhibition of benzo(a)pyrene and aflatoxin B, metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Fes41:67–72.
5.
Bundesanzeiger. (1984) No. 1, January 31.
6.
Conney AH. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res42:4875–917.
7.
Crebelli R, Aquilina G, Falcone E, Carere A. (1987) Urinary and faecal mutagenicity in Sprague- Dawley rats dosed with food mutagens quercetin and rutin. Food Chem Toxicol25:9–17.
8.
German Pharmacopoeia Dab 10. (1991) 10th Ed. Vol. 3, Stuttgart: Deutscher Apothekerverlag; Frankfurt: Govi Verlag GmbH.
Ito N, Hagiwara A, Tamano S, et al. (1989) Lack of carcinogenicity of quercetin in F344/DuCrj rats. Jpn J Cancer Res80:317–25.
11.
Kubo M, Matsuda H, Tani T, Arichi S, Kimura Y, Okuda H. (1985) Studies on Scutellariae radix. XII. Antithrombic actions of various flavonoids from Scutellariae radix. Chem Pharm Bull Tokyo33:2411–5.
12.
Kuhnau J. (1976) The flavonoids, a class of semi-essential food components. World Rev Nutr Diet24:117–91.
13.
MacGregor JT. (1979) Mutagenicity studies of flavonoids in vivo and in vitro [Abstract No. 94], Toxicol Appl Pharmacol48:A47.
14.
Mader JA, MacDonald IA. (1985) Effect of bile acids on formation of the mutagen quercetin from two flavonol glycoside precursors by human gut bacterial preparations. Mutat Res155:99–104.
15.
Matsukawa Y, Yoshida M, Sakai T, et al. (1990) The effect of quercetin and other flavonoids on cell cycle progression and growth of human gastric cancer cells. Planta Med56:677–8.
16.
Schimmer O, Hafele F, Kruger A. (1988) The mutagenic potencies of plant extracts containing quercetin in Salmonella typhimurium TA 98 and TA 100. Mutat Res206:201–8.
17.
Veckenstedt A, Pusztai R. (1981) Mechanism of antiviral action of quercetin against cardiovirus infection in mice. Antiviral Res1:249–61.
18.
Verma AK, Johnson JA, Gould MN, Tanner MA. (1988) Inhibition of 7,12-dimethyl- benz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by the dietary Flavonol quercetin. Cancer Res48:5754–8.
19.
Wacker A, Eilmes HG. (1978) Antivirale Wirkung von Pflanzeninhaltsstoffen. 1. Mitteilung: flavonoide. Arzneimiltelforschung28:347–50.
20.
Wagner H, Tittel GT, Bladt S. (1983) Analyse und Standardisierung von Arzneidrogen and Phytopra- paraten durch Hochleistungsfliissigchromatographie (HPLC) und andere chromatographische Verfahren. Deutsch Apotheker Ztung11:515–21.
21.
Willhite CC. (1982) Teratogenic potential of quercetin in the rat. Food Chem Toxicol20:75–9.
22.
Yonnes M, Siegers CP. (1981) Inhibitory action of some flavonoids on enhanced spontaneous lipid peroxidation following glutathione depletion. Planta Med43:240–4.
